Sorafenib 13C D3
| Product Name | Sorafenib 13C D3 |
|---|---|
| Alternate Names | Sorafenib Stable Isotopes, Stable Isotopes of Sorafenib |
| CAT No. | CS-O-06977 |
| CAS No. | 1210608-86-8 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 468.8 g/mol |
| Mol. For. | C2013CH13D3ClF3N4O3 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Sorafenib |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
| Canonical Smiles | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
| InchIKey | MLDQJTXFUGDVEO-KQORAOOSSA-N |
| Inchl | InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)/i1+1D3 |
| IUPAC | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(trideuterio(113C)methyl)pyridine-2-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Sorafenib 13C D3 is a chemotherapy medication used to treat advanced kidney cancer and liver cancer. It is a highly potent and selective inhibitor of multiple kinases, including RAF kinase, vascular endothelial growth factor receptor (VEGFR), and platelet-derived growth factor receptor (PDGFR). Sorafenib 13C D3 works by interfering with the growth and spread of cancer cells, which slows down the progression of cancer.
The chemical formula of Sorafenib 13C D3 is C21H12ClF3N4O3, with a molecular weight of 464.8 g/mol. It is a white crystalline powder that is highly soluble in water and organic solvents, such as methanol, ethanol, and dimethyl sulfoxide (DMSO).
Sorafenib 13C D3 is administered orally in the form of tablets, usually twice a day. The recommended dosage varies depending on the type of cancer being treated and the patient's body weight and overall health. It is important to follow the dosage instructions provided by the doctor or pharmacist, as overdosing or underdosing can have serious consequences.
Like all medications, Sorafenib 13C D3 can cause side effects, including fatigue, nausea, diarrhea, loss of appetite, and skin rash. It may also cause more serious side effects, such as bleeding, high blood pressure, and heart problems. Patients should report any side effects to their doctor immediately.
In conclusion, Sorafenib 13C D3 is a potent chemotherapy medication used to treat advanced kidney and liver cancer. It works by inhibiting multiple kinases, slowing down the progression of cancer. While it can cause side effects, it is an important tool in the fight against cancer.
Get an Instant Quote
Related Compounds
Sorafenib N-Oxide 13CD3 | Sorafenib 15ND3 | Sorafenib D3 | Sorafenib-d4 |